tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
:PAR
Australian Market
Advertisement

Paradigm Biopharmaceuticals (PAR) Ratios

Compare
37 Followers

Paradigm Biopharmaceuticals Ratios

AU:PAR's free cash flow for Q4 2025 was AU$-1.31. For the 2025 fiscal year, AU:PAR's free cash flow was decreased by AU$ and operating cash flow was AU$-537.72. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
29.98 7.22 4.89 6.02 13.98
Quick Ratio
29.98 7.22 4.89 6.02 13.98
Cash Ratio
23.01 5.30 4.32 5.07 12.26
Solvency Ratio
-11.89 -16.32 -3.86 -4.66 -5.23
Operating Cash Flow Ratio
-21.49 -19.63 -3.46 -4.11 -6.03
Short-Term Operating Cash Flow Coverage
0.00 -541.23 0.00 0.00 0.00
Net Current Asset Value
AU$ 20.74MAU$ 20.67MAU$ 50.39MAU$ 38.79MAU$ 74.46M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.01 <0.01 0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.04 1.15 1.25 1.20 1.08
Debt Service Coverage Ratio
-2.01K -429.99 -3.17K -1.36K -895.63
Interest Coverage Ratio
-2.70K -4.54K -3.61K -1.64K -1.12K
Debt to Market Cap
0.00 <0.01 0.00 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.67 0.27 0.95 0.83 1.67
Profitability Margins
Gross Profit Margin
-13.34%86.34%-268.87%-325.38%-1404.61%
EBIT Margin
-25834.74%-98306.99%-126038.89%-59304.70%-207339.00%
EBITDA Margin
-25658.41%-98083.59%-126309.13%-59095.03%-205029.78%
Operating Profit Margin
-25834.74%-99077.51%-126637.75%-59338.96%-206051.97%
Pretax Profit Margin
-25377.01%-89138.30%-126074.01%-59340.83%-207522.57%
Net Profit Margin
-18932.18%-89138.30%-111013.71%-49542.54%-166896.27%
Continuous Operations Profit Margin
-18932.18%-89138.30%-111013.71%-49542.54%-166896.27%
Net Income Per EBT
74.60%100.00%88.05%83.49%80.42%
EBT Per EBIT
98.23%89.97%99.55%100.00%100.71%
Return on Assets (ROA)
-76.39%-214.14%-77.40%-77.43%-40.45%
Return on Equity (ROE)
-67.96%-246.38%-96.71%-92.76%-43.82%
Return on Capital Employed (ROCE)
-108.50%-271.29%-109.60%-109.69%-53.60%
Return on Invested Capital (ROIC)
-80.47%-241.23%-96.32%-91.26%-43.03%
Return on Tangible Assets
-77.70%-239.96%-80.96%-82.21%-41.91%
Earnings Yield
-13.97%-68.96%-18.61%-17.48%-7.96%
Efficiency Ratios
Receivables Turnover
0.00 0.01 <0.01 0.01 <0.01
Payables Turnover
0.17 <0.01 0.01 0.05 0.06
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.70 0.35 0.14 0.14 0.03
Asset Turnover
<0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Cash Conversion Cycle
34.71K -86.37K 27.40K 23.28K 145.22K
Days of Sales Outstanding
44.64K 28.19K 53.14K 30.95K 151.11K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
9.93K 114.57K 25.73K 7.68K 5.89K
Operating Cycle
44.64K 28.19K 53.14K 30.95K 151.11K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.07 -0.22 -0.16 -0.13 -0.16
Free Cash Flow Per Share
-0.02 -0.22 -0.16 -0.13 -0.16
CapEx Per Share
0.04 0.22 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
0.36 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-1.55 -1.00 0.00 0.00 -1.10K
Capital Expenditure Coverage Ratio
-1.55 -1.00 0.00 0.00 -1.10K
Operating Cash Flow Coverage Ratio
-127.57 -275.54 -132.25 -52.22 -46.46
Operating Cash Flow to Sales Ratio
-280.50 -1.00K -966.34 -406.51 -1.70K
Free Cash Flow Yield
-11.26%-77.53%-16.20%-14.34%-8.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.59 -1.45 -5.37 -5.72 -12.56
Price-to-Sales (P/S) Ratio
1.67K 1.29K 5.97K 2.83K 20.96K
Price-to-Book (P/B) Ratio
3.48 3.57 5.20 5.31 5.50
Price-to-Free Cash Flow (P/FCF) Ratio
-16.78 -1.29 -6.17 -6.97 -12.32
Price-to-Operating Cash Flow Ratio
-5.13 -1.29 -6.17 -6.97 -12.33
Price-to-Earnings Growth (PEG) Ratio
-0.10 -0.13 -0.43 0.00 -0.07
Price-to-Fair Value
3.48 3.57 5.20 5.31 5.50
Enterprise Value Multiple
-5.35 -1.05 -3.77 -3.96 -8.56
Enterprise Value
125.26M 67.47M 222.95M 185.48M 360.47M
EV to EBITDA
-4.96 -1.05 -3.77 -3.96 -8.56
EV to Sales
2.40K 1.03K 4.77K 2.34K 17.54K
EV to Free Cash Flow
-7.83 -1.02 -4.93 -5.76 -10.31
EV to Operating Cash Flow
-7.83 -1.02 -4.93 -5.76 -10.32
Tangible Book Value Per Share
0.09 0.07 0.18 0.16 0.35
Shareholders’ Equity Per Share
0.10 0.08 0.19 0.18 0.37
Tax and Other Ratios
Effective Tax Rate
0.25 0.10 0.12 0.17 0.20
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.04 -0.20 -0.18 -0.16 -0.16
Tax Burden
0.74 1.00 0.88 0.83 0.80
Interest Burden
1.00 0.91 1.00 1.00 1.00
Research & Development to Revenue
340.39 886.53 1.13K 492.43 1.63K
SG&A to Revenue
42.05 94.47 140.39 100.15 425.70
Stock-Based Compensation to Revenue
1.25 0.00 20.03 41.28 156.02
Income Quality
0.85 1.12 0.87 0.82 1.02
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis